Inclisiran (Leqvio) Real-World Evidence: What Registries Show for Women
Real-world registry data on inclisiran (Leqvio): LDL-C reductions, persistence, safety in women with FH and ASCVD across life stages.
Read clinical reviewTopic Hub
6 clinically reviewed articles, written and peer-reviewed by the WomanRx.com Medical Team.
Explore
Showing 6 of 6 clinical reviews.
Real-world registry data on inclisiran (Leqvio): LDL-C reductions, persistence, safety in women with FH and ASCVD across life stages.
Read clinical reviewCompare Leqvio (inclisiran) cost against PCSK9 inhibitors and statins for high LDL. Women-specific dosing, pregnancy safety, and life-stage guidance.
Read clinical reviewComplete Leqvio monitoring schedule for women: which labs to check, how often, and what changes during perimenopause, PCOS, pregnancy, and postmenopause.
Read clinical reviewLeqvio (inclisiran) cuts LDL cholesterol ~50% with two injections per year. Here is what the FDA safety record means for women across every life stage.
Read clinical reviewThinking about stopping Leqvio? Learn what happens to your LDL-C, the rebound timeline, and how to safely discontinue inclisiran across every life stage.
Read clinical reviewA clinician-reviewed guide to switching between inclisiran (Leqvio) and other LDL-lowering drugs, with women-specific dosing, pregnancy safety, and life-stage guidance.
Read clinical review